Roffman Miller Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
38,953
+1,551
| +4% | +$629K | 0.94% | 41 |
|
|
2025
Q1 | $18.6M | Buy |
37,402
+898
| +2% | +$447K | 1.17% | 34 |
|
|
2024
Q4 | $19M | Buy |
36,504
+635
| +2% | +$330K | 1.17% | 34 |
|
|
2024
Q3 | $22.2M | Buy |
35,869
+647
| +2% | +$400K | 1.35% | 31 |
|
|
2024
Q2 | $19.5M | Buy |
35,222
+721
| +2% | +$399K | 1.28% | 32 |
|
|
2024
Q1 | $20.1M | Buy |
34,501
+1,008
| +3% | +$586K | 1.34% | 32 |
|
|
2023
Q4 | $17.8M | Buy |
33,493
+945
| +3% | +$502K | 1.27% | 36 |
|
|
2023
Q3 | $16.5M | Buy |
32,548
+530
| +2% | +$268K | 1.31% | 34 |
|
|
2023
Q2 | $16.7M | Buy |
32,018
+1,129
| +4% | +$589K | 1.26% | 34 |
|
|
2023
Q1 | $17.8M | Sell |
30,889
-227
| -0.7% | -$131K | 1.42% | 29 |
|
|
2022
Q4 | $17.1M | Buy |
31,116
+166
| +0.5% | +$91.4K | 1.41% | 30 |
|
|
2022
Q3 | $15.7M | Buy |
30,950
+498
| +2% | +$253K | 1.43% | 30 |
|
|
2022
Q2 | $16.5M | Buy |
30,452
+300
| +1% | +$163K | 1.43% | 30 |
|
|
2022
Q1 | $17.8M | Buy |
30,152
+193
| +0.6% | +$114K | 1.32% | 32 |
|
|
2021
Q4 | $20M | Buy |
29,959
+449
| +2% | +$300K | 1.35% | 32 |
|
|
2021
Q3 | $16.9M | Buy |
29,510
+1,102
| +4% | +$630K | 1.25% | 33 |
|
|
2021
Q2 | $14.3M | Buy |
28,408
+1,535
| +6% | +$774K | 1.09% | 37 |
|
|
2021
Q1 | $12.3M | Buy |
26,873
+2,519
| +10% | +$1.15M | 1.02% | 37 |
|
|
2020
Q4 | $11.3M | Buy |
24,354
+861
| +4% | +$401K | 0.98% | 37 |
|
|
2020
Q3 | $10.4M | Buy |
23,493
+693
| +3% | +$306K | 1% | 37 |
|
|
2020
Q2 | $8.26M | Buy |
22,800
+2,610
| +13% | +$946K | 0.82% | 38 |
|
|
2020
Q1 | $5.73M | Buy |
20,190
+3,153
| +19% | +$894K | 0.72% | 39 |
|
|
2019
Q4 | $5.54M | Buy |
17,037
+7,001
| +70% | +$2.27M | 0.55% | 42 |
|
|
2019
Q3 | $2.92M | Buy |
+10,036
| New | +$2.92M | 0.31% | 45 |
|